Syndax Pharmaceuticals, Inc. (SNDX)

NASDAQ: SNDX · Real-Time Price · USD

20.67

-0.08 (-0.39%)

At close: Feb 26, 2026, 4:00 PM EST

20.44

-0.23 (-1.11%)

After-hours: Feb 26, 2026, 6:49 PM EST

Syndax Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	111.3	23.68	-	-	139.71	1.52
Revenue Growth (YoY)	595.65%	-	-	-	9109.56%	-
Cost of Revenue	244.53	242.47	163.03	118.5	-	-
Gross Profit	-133.23	-218.79	-163.03	-118.5	139.71	1.52
Selling, General & Admin	167.44	120.88	66.92	33.26	25.24	22.51
Research & Development	6.23	-	-	-	88.25	50.44
Operating Expenses	173.67	120.88	66.92	33.26	113.49	72.94
Operating Income	-306.9	-339.67	-229.95	-151.76	26.22	-71.42
Interest Expense	-29	-4.93	-0.21	-3.14	-1.9	-2.36
Interest & Investment Income	25.51	26.09	21.16	5.87	0.4	0.84
Other Non Operating Income (Expenses)	-1.19	-0.25	-0.36	-0.32	0.2	-0.22
Pretax Income	-311.58	-318.76	-209.36	-149.34	24.93	-73.16
Net Income	-311.58	-318.76	-209.36	-149.34	24.93	-73.16
Preferred Dividends & Other Adjustments	-	-	-	-	-	3.91
Net Income to Common	-311.58	-318.76	-209.36	-149.34	24.93	-77.06
Shares Outstanding (Basic)	87	86	70	61	52	41
Shares Outstanding (Diluted)	87	86	70	61	54	41
Shares Change (YoY)	5.39%	21.67%	15.82%	13.31%	29.81%	35.48%
EPS (Basic)	-3.60	-3.72	-2.98	-2.46	0.48	-1.87
EPS (Diluted)	-3.60	-3.72	-2.98	-2.46	0.46	-1.87
Free Cash Flow	-311.01	-274.9	-160.6	-133.68	29	-71.26
Free Cash Flow Per Share	-3.59	-3.21	-2.28	-2.20	0.54	-1.73
Gross Margin	-119.70%	-	-	-	100.00%	100.00%
Operating Margin	-275.73%	-1434.43%	-	-	18.77%	-4708.17%
Profit Margin	-279.93%	-1346.11%	-	-	17.84%	-5080.03%
Free Cash Flow Margin	-279.43%	-1160.91%	-	-	20.76%	-4697.43%
EBITDA	-306.9	-339.66	-229.94	-151.72	26.26	-71.33
EBITDA Margin	-275.73%	-	-	-	18.80%	-
D&A For EBITDA	0	0.01	0.01	0.03	0.04	0.09
EBIT	-306.9	-339.67	-229.95	-151.76	26.22	-71.42
EBIT Margin	-275.73%	-	-	-	18.77%	-
Revenue as Reported	111.3	23.68	-	-	139.71	1.52
Advertising Expenses	-	7.3	6.1	1.5	-	-

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q